Health Care & Life Sciences » Pharmaceuticals | Gedeon Richter Nyrt.

Gedeon Richter Nyrt. | Cash Flow

Fiscal year is January-December. All values HUF Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
42,766
24,950
59,877
68,226
13,901
43,953
Depreciation, Depletion & Amortization
28,301
29,363
31,248
32,895
34,747
34,907
Other Funds
5,986
7,434
670
5,161
45,453
22,936
Funds from Operations
77,053
61,747
90,455
95,960
94,101
101,796
Changes in Working Capital
1,933
4,001
7,234
13,183
8,116
812
Net Operating Cash Flow
78,986
65,748
97,689
82,777
85,985
102,608
Capital Expenditures
33,606
43,234
33,302
36,453
39,929
Sale of Fixed Assets & Businesses
429
444
1,332
401
957
Purchase/Sale of Investments
7,877
774
-
-
733
Net Investing Cash Flow
40,071
49,137
41,742
96,359
48,695
Cash Dividends Paid - Total
12,263
10,603
6,245
13,563
19,756
Issuance/Reduction of Debt, Net
14,704
4,702
14,626
6,813
36,582
Net Financing Cash Flow
30,819
25,104
23,413
22,134
60,196
Net Change in Cash
5,366
8,637
34,434
36,321
20,012
Free Cash Flow
53,684
37,342
69,981
52,226
55,657
Net Assets from Acquisitions
647
7,214
25,322
63,555
8,045
Other Sources
1,630
93
18,429
3,950
-
Change in Capital Stock
3,852
9,799
2,542
1,758
3,858
Exchange Rate Effect
2,730
144
1,900
605
2,894
Other Uses
-
-
2,879
702
2,411

About Gedeon Richter Nyrt.

View Profile
Address
Gyömrõi út 19-21
Budapest BU 1103
Hungary
Employees -
Website http://www.richter.hu
Updated 07/08/2019
The Chemical Works of Gedeon Richter Plc engages in the development and manufacture of pharmaceuticals. It operates through the following segments: Pharmaceuticals, Wholesale and Retail, and Others. The Pharmaceutical segment is comprised of the subsidiaries of the group which are mainly engages in the research and development together with manufacturing and sale of pharmaceutical products.